Intelligent computation in cancer gene therapy

In recent years, the use of gene therapy for the treatment of disease has gained substantial interest, both in academic research and in the biomedical industry. Initial experimentation in gene therapy has generated positive results, as well as questions regarding safety. However, lessons have been learned from these first investigations, among them a realization that such treatments require a method to fine-tune the expression of therapeutic genes in real-time. A logical solution to this problem arose through the field of synthetic biology in the form of synthetic gene circuits. Thus, the synthetic biology community today aims to create "smart cells" for a variety of gene therapy applications, in an attempt to precisely target malignant cells while avoiding harming healthy ones. To generate safer and more effective gene therapies, new approaches with emerging computational abilities are necessary. In this review, we present several computational approaches which allow demonstrating artificial intelligence in living cells. Specifically, we will focus on implementing artificial neural networks using synthetic gene regulatory networks for cancer therapy and discuss the state-of-the-art computational developments.